Zahnmedizin up2date, Table of Contents Zahnmedizin up2date 2016; 10(04): 303-323DOI: 10.1055/s-0042-103063 Oralmedizin Georg Thieme Verlag KG Stuttgart · New York Analgetika und Antiphlogistika in der Zahn-, Mund- und Kieferheilkunde Pascal Oppel Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 International Association for the Study of Pain. Face Pain Scale – revised. Pain 2001; 93: 173-183 2 International Association for the Study of Pain. Merskey H, Bogduk N. Classification of chronic pain. Im Internet: http://www.iasp-pain.org/files/Content/ContentFolders/Publications2/FreeBooks/Classification-of-Chronic-Pain.pdf Stand: 05.06.2016 3 Reinold H, Ahmadi S, Depner UB et al. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest 2005; 115: 673-679 4 Samad TA, Moore KA, Sapirstein A et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410: 471-475 5 Catella-Lawson F, Reilly MP, Kapoor SC et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001; 345: 1809-1817 6 Kaufman DW, Kelly JP, Sheehan JE et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485-494 7 Hersh EV, Moore PA, Ross GL. Over-the-counter analgesics and antipyretics: a critical assessment. Clin Ther 2000; 22: 500-548 8 García Rodríguez LA, Hernández-Díaz S, de Abajo FJ. Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol 2001; 52: 563-571 9 Brune K. Lebertoxizität von Paracetamol. Der Internist 2007; 9: 1036-1038 10 Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 2008; 22: 383-390 11 Lee WM. Acetaminophen toxicity: changing perceptions on a social/medical issue. Hepatology 2007; 46: 966-970 12 Watkins PB, Kaplowitz N, Slattery JT et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006; 296: 87-93 13 Elmquist WF, Chan KK, Sawchuk RJ. Transsynovial drug distribution: synovial mean transit time of diclofenac and other nonsteroidal antiinflammatory drugs. Pharm Res 1994; 11: 1689-1697 14 Liauw HL, Ku E, Brandt KD et al. Effects of Voltaren on arachidonic acid metabolism in arthritis patients. Agents Actions Suppl 1985; 17: 195-199 15 Deutsche Gesellschaft für Neurologie. Leitlinie „Chronische neuropathische Schmerzen, Pharmakologische nicht interventionelle Therapie“, Registernummer 030 - 114, gültig bis 31.12.2016, 2012. Im Internet: http://www.awmf.org/leitlinien/detail/ll/030-114.html Stand: 05.06.2016 16 Deutsche Gesellschaft für Neurologie. Leitlinie „Neuropathische Schmerzen, Diagnostik“, Registernummer 030 - 132, gültig bis 31.12.2016, 2012. Im Internet: http://www.awmf.org/leitlinien/detail/ll/030-132.html Stand: 05.06.2016 17 Brune K. The early history of non-opioid analgesics. Acute Pain 1997; 1: 33-40 18 Arzneimittelkommission der Deutschen Ärzteschaft. UAW-News International Nichtsteroidale Antirheumatika (NSAR) im Vergleich: Risiko von Komplikationen im oberen Gastrointestinaltrakt, Herzinfarkt und Schlaganfall. Dtsch Ärztebl 2013; 110: A-1447/B-1271/C-1255 19 Brune K, Zeilhofer HU. Antipyretic Analgesics: basic Aspects. In: McMahon SB, Koltzenburg M, eds. Wall and Melzackʼs Textbook of Pain. 6th ed. Edinburgh: Churchill Livingstone; 2006: 459-469 20 Hinz B, Cheremina O, Besz D et al. Impact of naproxen sodium at over-the-counter doses on cyclooxygenase isoforms in human volunteers. Int J Clin Pharmacol Ther 2008; 46: 180-186 21 Ishikawa TO, Jain NK, Taketo MM et al. Imaging cyclooxygenase-2 (Cox-2) gene expression in living animals with a luciferase knock-in reporter gene. Mol Imaging Biol 2006; 8: 171-187 22 Cannon CP, Curtis SP, FitzGerald GA et al. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 2006; 368: 1771-1781 23 Deutsche Interdisziplinäre Vereinigung für Schmerztherapie. Leitlinie „Behandlung akuter perioperativer und posttraumatischer Schmerzen“, 2009. Im Internet: http://www.awmf.org/leitlinien/detail/ll/001-025.html Stand: 05.06.2016 24 Schaefer C, Spielmann H, Vetter K et al. Arzneimittel in Schwangerschaft und Stillzeit. 8. Aufl. München: Elsevier; 2012 25 Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie. Informationen zu Medikamentenwirkungen in der Schwangerschaft und Stillzeit. Im Internet: http://www.embryotox.de/wirkstoffe.html Stand: 05.06.2016 26 Boelsterli UA. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol 2003; 192: 307-322 27 Flower RJ. The development of COX2 inhibitors. Nat Rev Drug Discov 2003; 2: 179-191 28 Hinz B, Dormann H, Brune K. More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib. Arthritis Rheum 2006; 54: 282-291 29 Renner B, Zacher J, Buvanendran A et al. Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery – a pilot study. Naunyn Schmiedebergs Arch Pharmacol 2010; 381: 127-136
